drugset / Trial / NCT00613665

Safety and Immunogenicity of Chiron's Investigational H. Pylori Vaccine in Healthy Adults

NCT00613665 ↗

Phase 1 Completed 113 enrolled Novartis Vaccines
RandomizedParallel-groupSingle-blindPrevention

Summary

This study was designed to investigate the safety and immunogenicity of Chiron's investigational H. pylori (HP3) vaccine

Timeline

Start
2001-02
Primary completion
2001-12
Completion
2002-04

Drugs

EvaluationDrugModalityDoseRoute
Subject HP3 Other / unclassified 10 ug Intramuscular
Subject HP3 Other / unclassified 25 ug Intramuscular